These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1260112)

  • 1. Biological implications of the reaction possibilities of the proximate carcinogenic compound, N-hydroxy-2-fluorenylacetamide.
    Lhoëst G; Razzouk C; Mercier M
    Biomed Mass Spectrom; 1976 Feb; 3(1):21-7. PubMed ID: 1260112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The proximo-distal carcinogen N-hydroxy-2-fluorenylacetamide, toxification and detoxification routes due to electrophilic and combined nucleophilic and electrophilic tautomerism effects.
    Lhoest G; Roberfroid M; Mercier M
    Biomed Mass Spectrom; 1978 Jan; 5(1):38-43. PubMed ID: 623892
    [No Abstract]   [Full Text] [Related]  

  • 3. Activation of the carcinogens N-hydroxy-N-2-fluorenylbenzamide and N-hydroxy-N-2-fluorenylacetamide via deacylations and acetyl transfers by rat peritoneal serosa and liver.
    Ritter CL; Malejka-Giganti D
    Carcinogenesis; 1994 Feb; 15(2):163-70. PubMed ID: 8313503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of susceptibility of F344 rats to mammary tumor induction by topically applied fluorenylacetohydroxamic acids and their acetates.
    Malejka-Giganti D; Rydell RE
    J Natl Cancer Inst; 1978 Feb; 60(2):433-5. PubMed ID: 621757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subnanogram estimation of the proximate carcinogen N-hydryxy-2-fluorenylacetamide by gas-liquid chromatography.
    Razzouk C; Lhoest G; Roberfroid M; Mercier M
    Anal Biochem; 1977 Nov; 83(1):194-203. PubMed ID: 920936
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative electrophilicity, mutagenicity, DNA repair induction activity, and carcinogenicity of some N- and O-acyl derivatives of N-hydroxy-2-aminoflourene.
    Bartsch H; Malaveille C; Stich HF; Miller EC; Miller JA
    Cancer Res; 1977 May; 37(5):1461-7. PubMed ID: 322856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of carcinogenic arylhydroxamic acids by human tissues.
    King CM; Olive CW; Cardona RA
    J Natl Cancer Inst; 1975 Aug; 55(2):285-7. PubMed ID: 1159819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The carcinogenicity of fluorenylhydroxamic acids and N-acetoxy-N-fluorenylacetamides for the rat as related to the reactivity of the esters toward nucleophiles.
    Yost Y; Gutmann HR; Rydell RE
    Cancer Res; 1975 Feb; 35(2):447-59. PubMed ID: 1109807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ON THE BINDING OF THE CARCINOGEN N-2-FLUORENYLACETAMIDE TO RAT SERUM ALBUMIN IN VIVO.
    BAHL OP; GUTMANN HR
    Biochim Biophys Acta; 1964 Aug; 90():391-3. PubMed ID: 14220723
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipid hydroperoxide activation of N-hydroxy-N-acetylaminofluorene via a free radical route.
    Floyd RA; Soong LM; Walker RN; Stuart M
    Cancer Res; 1976 Aug; 36(8):2761-7. PubMed ID: 1277186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-sulfonation of N-hydroxy-2-fluorenylacetamide and 7-hydroxy-N-2-fluorenylacetamide in fetal and placental tissues of humans and guinea pigs.
    Namkung MJ; Zachariah PK; Juchau MR
    Drug Metab Dispos; 1977; 5(3):288-94. PubMed ID: 17528
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of N-(deoxyguanosin-8-yl)-2-fluorenamine in DNA of peritoneal serosa and liver after intraperitoneal exposure of rats to N-hydroxy-N-2-fluorenylbenzamide or N-hydroxy-N-2-fluorenylacetamide.
    Malejka-Giganti D; Ritter CL; Fullerton NF; Beland FA
    Carcinogenesis; 1994 Dec; 15(12):2883-90. PubMed ID: 8001251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of the inhibitory action of p-hydroxyacetanilide on carcinogenesis by N-2-fluorenylacetamide or N-hydroxy-N-2-fluorenylacetamide.
    Mohan LC; Grantham PH; Weisburger EK; Weisburger JH; Idoine JB
    J Natl Cancer Inst; 1976 Apr; 56(4):763-8. PubMed ID: 815562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAT LIVER AFTER N-HYDROXY-2-ACETYLAMINOFLUORENE. ULTRASTRUCTURE.
    HARTMANN HA
    Arch Pathol; 1965 Feb; 79():126-34. PubMed ID: 14232928
    [No Abstract]   [Full Text] [Related]  

  • 15. Horseradish peroxidase/hydrogen peroxide-catalyzed oxidation of the carcinogen N-hydroxy-N-acetyl-2-aminofluorene as effected by cyanide and ascorbate.
    Floyd RA; Soong LM; Culver PL
    Cancer Res; 1976 Apr; 36(4):1510-9. PubMed ID: 1260768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel oxidation of the carcinogen N-hydroxy-N-2-fluorenylacetamide catalyzed by peroxidase/H2O2/Br-.
    Ritter CL; Malejka-Giganti D
    Biochem Biophys Res Commun; 1985 Aug; 131(1):174-81. PubMed ID: 4038295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of reducing agents on N-acetoxy- and N-hydroxy-2-acetylaminofluorene-induced mutagenesis.
    Rosin MP; Stich HF
    Cancer Res; 1978 May; 38(5):1307-10. PubMed ID: 346207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of N-hydroxy-2-acetylaminofluorene and N-hydroxy-2-aminofluorene by guinea pig liver microsomes.
    Razzouk C; Batardy-Grégoire M; Roberfroid M
    Cancer Res; 1982 Nov; 42(11):4712-8. PubMed ID: 7127306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initiation of hepatocarcinogenesis in infant male B6C3F1 mice by N-hydroxy-2-aminofluorene or N-hydroxy-2-acetylaminofluorene depends primarily on metabolism to N-sulfooxy-2-aminofluorene and formation of DNA-(deoxyguanosin-8-yl)-2-aminofluorene adducts.
    Lai CC; Miller EC; Miller JA; Liem A
    Carcinogenesis; 1987 Mar; 8(3):471-8. PubMed ID: 3815742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the carcinogen N-hydroxy-2-acetylaminofluorene by rat mammary peroxidase.
    Reigh DL; Stuart M; Floyd RA
    Experientia; 1978 Jan; 34(1):107-8. PubMed ID: 620717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.